| For: | Nishida A, Nishino K, Sakai K, Owaki Y, Noda Y, Imaeda H. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease? World J Gastroenterol 2021; 27(23): 3317-3326 [PMID: 34163114 DOI: 10.3748/wjg.v27.i23.3317] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i23/3317.htm |
| Number | Citing Articles |
| 1 |
Chi Yan, Shou-He Huang, Hua-Fang Ding, Erika Kwek, Jian-Hui Liu, Zi-Xing Chen, Ka Ying Ma, Zhen-Yu Chen. Adverse effect of oxidized cholesterol exposure on colitis is mediated by modulation of gut microbiota. Journal of Hazardous Materials 2023; 459 doi: 10.1016/j.jhazmat.2023.132057
|
| 2 |
Antonio Pellegrino, Gaetano Coppola, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani. Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties. Nutrients 2023; 15(8) doi: 10.3390/nu15081815
|
| 3 |
Meitong Guo, Xingchen Du, Xiaoyan Wang. Inhibition of ferroptosis: A new direction in the treatment of ulcerative colitis by traditional Chinese medicine. Journal of Ethnopharmacology 2024; 324 doi: 10.1016/j.jep.2024.117787
|
| 4 |
Omar P. Vallejos, Susan M. Bueno, Alexis M. Kalergis. Probiotics in inflammatory bowel disease: microbial modulation and therapeutic prospects. Trends in Molecular Medicine 2025; 31(8) doi: 10.1016/j.molmed.2024.12.005
|
| 5 |
Niloofar Rezaie, Shadi Aghamohammad, Elham Haj Agha Gholizadeh Khiavi, Malihe Talebi, Mohammad Reza Pourshafie, Mahdi Rohani. The comparison of antioxidant and anti-inflammatory potency of native probiotics and paraprobiotics in DSS-induced colitis mice with a normal diet. Genes & Nutrition 2025; 20(1) doi: 10.1186/s12263-025-00774-9
|
| 6 |
Mithun Rudrapal, André M. de Oliveira, Ravi Pratap Singh. Dietary polyphenols maintain human health through modulation of gut microbiota. Frontiers in Pharmacology 2026; 16 doi: 10.3389/fphar.2025.1710088
|
| 7 |
Xiaolin Xu, Liang Li, Xiaoting Li, Yunyi Wang, Minghao Huang, Huajiao Wu, Huijing Liang, Xiaolei Ze, Fang He, Xi Shen. Bifidobacterium breve207-1 protects against later-life colitis following early-life antibiotic exposure by enhancing intestinal barrier and immune homeostasis. BMC Gastroenterology 2026; 26(1) doi: 10.1186/s12876-026-04953-9
|
| 8 |
Si Wang, Lei Li, Yuhan Chen, Qian Liu, Shengyu Zhou, Ning Li, Yueying Wu, Jiali Yuan. Houttuynia cordata thunb. alleviates inflammatory bowel disease by modulating intestinal microenvironment: a research review. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1306375
|
| 9 |
Shaowei Huang, Qiujuan Ye, Anjiang Wang, Ye Chen. Paeoniae Decoction restores intestinal barrier dysfunction by promoting the interaction between ILC3 and gut flora. Phytomedicine 2024; 132 doi: 10.1016/j.phymed.2024.155873
|
| 10 |
Peter C. Konturek. Darmmikrobiom und chronisch- entzündliche Darmerkrankung. MMW - Fortschritte der Medizin 2022; 164(S7) doi: 10.1007/s15006-022-1230-3
|
| 11 |
Cheng-Mei Tian, Mei-Feng Yang, Chen Kong, Duo Luo, Ning-Ning Yue, Hai-Lan Zhao, Yuan Zhang, Jian-Ping Lu, Yu-Jie Liang, Yang Song, Dao-Ru Wei, Jun Yao, Li-Sheng Wang, De-Feng Li. Microbiome–Gut–Brain Axis: Implications for the Links Between Inflammatory Bowel Disease and Neuropsychiatric Disorders. Journal of Inflammation Research 2025; doi: 10.2147/JIR.S514838
|
| 12 |
EXPLORING THE THERAPEUTIC POTENTIAL OF FECAL MICROBIOTA TRANSPLANTATION IN INFLAMMATORY BOWEL DISEASE. International Journal of Innovative Technologies in Social Science 2025; (4(48)) doi: 10.31435/ijitss.4(48).2025.4160
|
| 13 |
Xiaohua Guo, Edozie Samuel Okpara, Wanting Hu, Chuyun Yan, Yu Wang, Qionglin Liang, John Y. L. Chiang, Shuxin Han. Interactive Relationships between Intestinal Flora and Bile Acids. International Journal of Molecular Sciences 2022; 23(15) doi: 10.3390/ijms23158343
|
| 14 |
Zhihao Wang, Min Gao, Juan Kan, Qingyang Cheng, Xiaotong Chen, Chao Tang, Dan Chen, Shuai Zong, Changhai Jin. Resistant Starch from Purple Sweet Potatoes Alleviates Dextran Sulfate Sodium-Induced Colitis through Modulating the Homeostasis of the Gut Microbiota. Foods 2024; 13(7) doi: 10.3390/foods13071028
|
| 15 |
Mengmeng Zhang, Xuan Qu. Research Progress on Mechanism of Shikonin in Treatment of Colitis. Journal of Contemporary Medical Practice 2024; 6(10) doi: 10.53469/jcmp.2024.06(10).34
|
| 16 |
Wei Sun, Zhibo Li, Xiaohao Zhang, Qiang Luo, Lijuan Wei, Chunsheng Xiao. Biomaterial-based therapeutic strategies for inflammatory bowel disease. Biomaterials 2026; 324 doi: 10.1016/j.biomaterials.2025.123462
|
| 17 |
Javier Martínez de Victoria Carazo, David Vinuesa García, Esther Serrano-Conde Sánchez, José Antonio Peregrina Rivas, Antonio José Ruíz Rodríguez, José Hernández Quero. Ruminococcus gnavus bacteremia: Literature review and a case report associated with acute flare of ulcerative colitis in an immunocompromised patient. Anaerobe 2023; 82 doi: 10.1016/j.anaerobe.2023.102762
|
| 18 |
Qianhui Fu, Xiaoqin Ma, Shuchun Li, Mengni Shi, Tianyuan Song, Jian Cui. New insights into the interactions between the gut microbiota and the inflammatory response to ulcerative colitis in a mouse model of dextran sodium sulfate and possible mechanisms of action for treatment with PE&AFWE. Animal Models and Experimental Medicine 2024; 7(2) doi: 10.1002/ame2.12405
|
| 19 |
Qi Wang, Wenwen Zhang, Jiaqin Liu, Wenjun Qin, Jin Cai. Exopolysaccharide of Levilactobacillus brevis M-10 Improved Physiological and Biochemical Indicators and Gut Microbiota in DSS-Induced Colitis Mice. Current Microbiology 2025; 82(5) doi: 10.1007/s00284-025-04190-5
|
| 20 |
Qinying Wang, Fanying Guo, Yutao Jin, Yanlei Ma. Applications of human organoids in the personalized treatment for digestive diseases. Signal Transduction and Targeted Therapy 2022; 7(1) doi: 10.1038/s41392-022-01194-6
|
| 21 |
Hyeonwoo Kim, Ji Eun Na, Sangsoo Kim, Tae-Oh Kim, Soo-Kyung Park, Chil-Woo Lee, Kyeong Ok Kim, Geom-Seog Seo, Min Suk Kim, Jae Myung Cha, Ja Seol Koo, Dong-Il Park. A Machine Learning-Based Diagnostic Model for Crohn’s Disease and Ulcerative Colitis Utilizing Fecal Microbiome Analysis. Microorganisms 2023; 12(1) doi: 10.3390/microorganisms12010036
|
| 22 |
Vincenza Tinnirello, Maria Grazia Zizzo, Alice Conigliaro, Mariangela Tabone, Nima Rabienezhad Ganji, Adele Cicio, Carlo Bressa, Mar Larrosa, Francesca Rappa, Giuseppe Vergilio, Roberta Gasparro, Alessia Gallo, Rosa Maria Serio, Riccardo Alessandro, Stefania Raimondo. Industrial-produced lemon nanovesicles ameliorate experimental colitis-associated damages in rats via the activation of anti-inflammatory and antioxidant responses and microbiota modification. Biomedicine & Pharmacotherapy 2024; 174 doi: 10.1016/j.biopha.2024.116514
|
| 23 |
Emília Hijová. Probiotics in IBD: Evidence and Perspectives on Patient Health and Disease Management. International Journal of Molecular Sciences 2025; 26(18) doi: 10.3390/ijms26189065
|
| 24 |
Pauline Raoul, Marco Cintoni, Marta Palombaro, Luisa Basso, Emanuele Rinninella, Antonio Gasbarrini, Maria Cristina Mele. Food Additives, a Key Environmental Factor in the Development of IBD through Gut Dysbiosis. Microorganisms 2022; 10(1) doi: 10.3390/microorganisms10010167
|
| 25 |
Lie Zheng, Xin-Li Wen, Sheng-Lei Duan. Role of metabolites derived from gut microbiota in inflammatory bowel disease. World Journal of Clinical Cases 2022; 10(9): 2660-2677 doi: 10.12998/wjcc.v10.i9.2660
|
| 26 |
Magdalena Stojek, Anna Jabłońska, Krystian Adrych. The Role of Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease. Journal of Clinical Medicine 2021; 10(18) doi: 10.3390/jcm10184055
|
| 27 |
Shanshan Li, Fuzhong Zhang, Qixiong Zhang. Pathological features-based targeted delivery strategies in IBD therapy: A mini review. Biomedicine & Pharmacotherapy 2022; 151 doi: 10.1016/j.biopha.2022.113079
|
| 28 |
Min Wang, Jingyan Shi, Chao Yu, Xinyi Zhang, Gaoxin Xu, Ziyan Xu, Yong Ma. Emerging strategy towards mucosal healing in inflammatory bowel disease: what the future holds?. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1298186
|
| 29 |
|
| 30 |
Nandu Goswami, Andrew Philip Blaber, Giovanna Valenti, Helmut Hinghofer-Szalkay, Joyce Evans, Damian Miles Bailey, Joan Vernikos, Alexander Choukér, David Andrew Green, Olivier White, Jack J. W. A. van Loon, Victor A. Convertino. Gravity, microgravity, and artificial gravity: physiological effects, implementation, and applications. Physiological Reviews 2026; 106(2) doi: 10.1152/physrev.00055.2024
|
| 31 |
Siyao Gu, Xiaona Zhao, Fang Wan, Dayong Gu, Weidong Xie, Cheng Gao. Intracellularly Gelated Macrophages Loaded with Probiotics for Therapy of Colitis. Nano Letters 2024; 24(43) doi: 10.1021/acs.nanolett.4c02699
|
| 32 |
Eduardo J. Villablanca, Katja Selin, Charlotte R. H. Hedin. Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression?. Nature Reviews Gastroenterology & Hepatology 2022; 19(8) doi: 10.1038/s41575-022-00604-y
|
| 33 |
Huanhuan Liu, Chunhong Yan, Yue Teng, Jian Guo, Chencheng Liang, Xiaodong Xia. Gut microbiota and d-ribose mediate the anti-colitic effect of punicalagin in DSS-treated mice. Food & Function 2024; 15(13) doi: 10.1039/D4FO00741G
|
| 34 |
Lie Zheng, Xin-Li Wen, Sheng-Lei Duan. Role of metabolites derived from gut microbiota in inflammatory bowel disease. World Journal of Clinical Cases 2022; 10(9) doi: 10.12998/wjcc.v10.i9.2658
|
| 35 |
Adrian Boicean, Dan Bratu, Sorin Radu Fleaca, Gligor Vasile, Leeb Shelly, Sabrina Birsan, Ciprian Bacila, Adrian Hasegan. Exploring the Potential of Fecal Microbiota Transplantation as a Therapy in Tuberculosis and Inflammatory Bowel Disease. Pathogens 2023; 12(9) doi: 10.3390/pathogens12091149
|
| 36 |
Mei Wang, Ruijia Fu, Dingqiao Xu, Yanyan Chen, Shijun Yue, Sai Zhang, Yuping Tang. Traditional Chinese Medicine: A promising strategy to regulate the imbalance of bacterial flora, impaired intestinal barrier and immune function attributed to ulcerative colitis through intestinal microecology. Journal of Ethnopharmacology 2024; 318 doi: 10.1016/j.jep.2023.116879
|
| 37 |
Céline Henry, Ariane Bassignani, Magali Berland, Olivier Langella, Harry Sokol, Catherine Juste. Modern Metaproteomics: A Unique Tool to Characterize the Active Microbiome in Health and Diseases, and Pave the Road towards New Biomarkers—Example of Crohn’s Disease and Ulcerative Colitis Flare-Ups. Cells 2022; 11(8) doi: 10.3390/cells11081340
|
| 38 |
Xiaochen Zhang, Dai Ishikawa, Toshifumi Ohkusa, Shinji Fukuda, Akihito Nagahara. Hot topics on fecal microbiota transplantation for the treatment of inflammatory bowel disease. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.1068567
|
| 39 |
Peijie Zhong, Hang Wu, Yuanqiao Ma, Xiaoxiao Xu, Yizhuo Jiang, Chaolei Jin, Qiaozhen Zhu, Xinlei Liu, Zhimin Suo, Junpeng Wang. P2X4 receptor modulates gut inflammation and favours microbial homeostasis in colitis. Clinical and Translational Medicine 2023; 13(4) doi: 10.1002/ctm2.1227
|
| 40 |
Alessia Ciafarone, Serena Artone, Valeria Ciummo, Francesca Rosaria Augello, Serena Altamura, Francesca Lombardi, Giovanni Latella, Paola Palumbo, Benedetta Cinque. Multi-Strain Probiotic Lysate Attenuates TGF-β1-Induced Intestinal Fibrosis and EMT Modulating Smad, Akt, and WNT/β-Catenin Pathways. Cells 2025; 14(18) doi: 10.3390/cells14181432
|
| 41 |
Meiyu Bao, Keyi Wang, Jingqiang Li, Yueying Li, Huanhuan Zhu, Meiling Lu, Yue Zhang, Qiangyuan Fan, Lin Han, Kesheng Wang, Dongyan Wang, Yan Gao, Bo Peng, Zunzhen Ming, Weiwei Liu. ROS Scavenging and inflammation-directed polydopamine nanoparticles regulate gut immunity and flora therapy in inflammatory bowel disease. Acta Biomaterialia 2023; 161 doi: 10.1016/j.actbio.2023.02.026
|
| 42 |
Jinglin Chen. The role of gut microbiota in the formation of IBD, a typical chronic intestinal inflammatory disease. Frontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1720709
|
| 43 |
Zhiguo Li, Shan Zhang, Li Xu, Xuexun Fang, Youzhong Wan, Dahai Yu, Yi Guo. A tetrapeptide from maize combined with probiotics exerted strong anti-inflammatory effects and modulated gut microbiota in DSS-induced colitis mice. Food & Function 2022; 13(24) doi: 10.1039/D2FO02678C
|
| 44 |
Yu-Yi Chen, Yu-Chun Lin, Yi-Lu Wu, Tsai-Hsuan Cheng, Man-Yun Hung, Yung-Tsung Chen, Jing-Yiing Wu, Cheng-Chin Kuo, Yen-Po Chen. Bovine raw milk-isolated Lacticaseibacillus paracasei RM081 with producing anti-inflammatory metabolite 5-methoxytryptophan ameliorates dextran sulfate sodium-induced colitis in mice. Applied Food Research 2026; 6(1) doi: 10.1016/j.afres.2026.102179
|
| 45 |
Linyuan Yi, Aijie Mo, Huijun Yang, Yifan Yang, Qian Xu, Yongchao Yuan. Integrative RNA, miRNA, and 16S rRNA sequencing reveals immune-related regulation network for glycinin-induced enteritis in hybrid yellow catfish, Pelteobagrus fulvidraco ♀ × Pelteobagrus vachelli ♂. Frontiers in Immunology 2025; 15 doi: 10.3389/fimmu.2024.1475195
|
| 46 |
Xinyue Yang, Mengmeng Sun, Min He, Zhihong Wang, Qingqing Tang, Tie Li. Acupuncture for inflammatory bowel disease: A protocol for systematic review and meta-analysis. Medicine 2022; 101(49) doi: 10.1097/MD.0000000000032236
|
| 47 |
Cong Zhang, Yong‐Wen Ouyang, Hui‐Xin He, Pei‐Zhu Su, Zhao‐Tao Li. The Emerging Role of CCL17 in the Immunologic Regulation of Inflammatory Bowel Disease. Journal of Gastroenterology and Hepatology 2025; 40(10) doi: 10.1111/jgh.70005
|
| 48 |
Hamide Busmail, Sasika Weerakoon, Bethel T Mandefro, Sri Vidya Sundara, Xinyu Lu, Sravanthi Avula, Lubna Mohammed. Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Systematic Review of Efficacy and Safety. Cureus 2026; doi: 10.7759/cureus.106453
|
| 49 |
Wen-wen Ma, Zhi-Qiang Huang, Kun Liu, De-Zhi Li, Tian-Lu Mo, Qing Liu. The role of intestinal microbiota and metabolites in intestinal inflammation. Microbiological Research 2024; 288 doi: 10.1016/j.micres.2024.127838
|
| 50 |
Peng Qiu, Takatsugu Ishimoto, Lingfeng Fu, Jun Zhang, Zhenyong Zhang, Yang Liu. The Gut Microbiota in Inflammatory Bowel Disease. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.733992
|
| 51 |
Sha Li, Hongdan Deng, Shu Fu, Juan Li, Xinyu Luo, Zhuoping Chen, Pei Wang, Xi Feng, Yi Chen, Chaomei Fu, Zhejie Chen, Shengpeng Wang. Oral probiotic delivery-based therapeutic strategies for inflammatory bowel disease. Asian Journal of Pharmaceutical Sciences 2026; 21(4) doi: 10.1016/j.ajps.2026.101187
|